Advances in Clinical and Experimental Medicine
2013, vol. 22, nr 4, July-August, p. 481–487
Publication type: original article
Language: English
Comparison of Topical Sucralfate and Silver Sulfadiazine Cream in Second Degree Burns in Rats
Porównanie skuteczności miejscowego sukralfatu i soli srebrowej sulfadiazyny w kremie w leczeniu oparzeń drugiego stopnia u szczurów
1 Qazvin University of Medical Sciences, Iran
Streszczenie
Wprowadzenie.Najbardziej rozpowszechnionym sposobem miejscowego leczenia oparzeń II stopnia jest sól srebrowa sulfadiazyny 1% (SSD). Ostatnie badania wykazały, że leczenie oparzeń II stopnia jest opóźnione z wykorzystaniem SSD. Jednym z możliwych opatrunków oparzeniowych jest sukralfat.
Cel pracy. Analiza porównawcza wpływu sukralfatu i SSD na oparzenia drugiego stopnia u szczurów.
Materiał i metody. Czterdzieści osiem samców szczurów podzielono na trzy równe grupy. Model oparzenia utworzono na grzbiecie wszystkich szczurów. Spalone obszary w grupach pierwszej, drugiej i trzeciej codziennie pokrywano odpowiednio sukralfatem, SSD i zimną śmietaną (grupa kontrolna). Na koniec dnia 7, 14, 21 i 28 szczury usypiano i spalone próbki tkanki skóry zebrano do badań histopatologicznych.
Wyniki. Na koniec badania naskórek i warstwa rogowa skóry były całkowicie uformowane w grupie SSD i sukralfatu, jednak skóra właściwa została wytworzona w grupie z sukralfatem. Skuteczność gojenia ran obliczono na 76%, 91% i 100% w grupie kontrolnej, z solą srebrową sulfadiazyny i z sukralfatem.
Wnioski. Sukralfat wywiera korzystny wpływ na gojenie ran. Przy zastosowaniu miejscowym sukralfat przyspieszał proces gojenia ran po oparzeniu w porównaniu z grupą kontrolną i SSD oraz może być stosowany jako alternatywa lub środek wspomagający leczenie w przyszłości.
Key words
sucralfate, silver sulfadiazine, second degree burns, rat.
Słowa kluczowe
sukralfat, sól srebrowa sulfadiazyny, drugi stopień oparzenia, szczur.
References (42)
- Demling RH: Burns and other thermal injuries. In: Current surgical diagnosis and treatment. eds.: lawrence W, Gerard M. lang Medical Books/McGraw-Hill, 2002, 267–281.
- Wilkinson E: The epidemiology of burns in secondary care, in a population of 2.6 million people. Burns 1998, 24, 139–143.
- Taddonio TE, Thomson PD, Smith DJ, Prasad JK: A survey of wound monitoring and topical antimicrobial therapy practices in the treatment of burn injury. J Burn Care Rehabil 1990, 11, 423–427.
- Gracia CG: An open study comparing topical silver sulfadiazine and topical silver sulfadiazine-cerium nitrate in the treatment of moderate and severe burns. Burns 2001, 27, 67–74.
- Gregory RS, Piccolo N, Piccolo MT, Piccolo MS, Heggers JP: Comparison of propolis skin cream to silver sulfadiazine: A naturopathic alternative to antibiotics in treatment of minor burns. J Altern Complementary Med 2002, 8, 77–83.
- Hosnuter M, Gurel A, Bauccu O, Armutcu F, Kargi E, Isikdemir A: The effect of CAPe on lipid peroxidation and nitric oxide levels in the plasma of rats following thermal injury. Burns 2004, 30, 121–125.
- Lee AR, Moon HK: effect of topically applied silver sulfadiazine on fibroblast cell proliferation and biomechanical properties of the wound. Arch Pharm Res 2003, 26, 855–860.
- Stern HS: Silver sulphadiazine and the healing of partial thickness burns: a prospective clinical trail. Br J Plast Surg 1989, 42, 581–585.
- Hayashi AH, Lau HY and Gillis DA: Topical sucralfate: effective therapy for the management of resistant peristomal and perineal excoriation. J Pediatr Surg 1991, 26, 1279–1281.
- Lyon CC, Stapleton M, Smith AJ, Griffiths CE, Beck MH: Topical sucralfate in the management of peristomal skin disease: an open study. Clin exp Dermatol 2000, 25, 584–588.
- Delaney G, Fisher R, Hook C, Barton M: Sucralfate cream in the management of moist desquamation during radiotherapy. Australas Radiol 1997, 41, 270–275.
- Maiche A, Isokangas OP, Grohn P: Skin protection by sucralfate cream during electron beam therapy. Acta Oncol 1994, 33, 201–203.
- Markham T, Kennedy F, Collins P: Topical sucralfate for erosive irritant diaper dermatitis. Arch Dermatol 2000, 136, 1199–1200.
- Lentz SS, Barrett RJ, Homesley HD: Topical sucralfate in the treatment of vaginal ulceration. Obstet Gynecol 1993, 81, 869–871.
- Marini I, Vecchiet F: Sucralfate: a help during oral management in patients with epidermolysis bullosa. J Periodontol 2001, 72, 691–695.
- Banati A, Chowdhury SR, Mazumder S: Topical use of Sucralfate Cream in second and third degree burns. Burns 2001, 27, 465–469.
- Tumino G, Masuelli L, Bei R, Simonelli L, Santoro A, Francipane S: Topical treatment of chronic venous ulcers with sucralfate: a placebo controlled randomized study. Int J Mol Med 2008, 22, 17–23.
- Tryba M, Mantey-Stiers F: Antibacterial activity of sucralfate in human gastric juice. Am J Med 1987, 83, 125–127.
- Kawazoe, H, Takaoka K., Shibata H, Arakaki N, Higuti T, Negayama K, Houchi H, Tsuchiya K, Takiguchi Y: Comparison of antibacterial activity of fluoroquinolones with their sucralfate-complexes against clinically-isolated bacteria. J Health Sci 2009, 55, 790–795.
- Gupta PJ, Heda PS, Kalaskar S, Tamaskar VP: Topical sucralfate decreases pain after hemorrhoidectomy and improves healing: a randomized, blinded, controlled study. Dis Colon Rectum 2008, 51, 231–234.
- Durmus AS, Han MC, Yaman I: Comparative evaluation of Collagenase and Silver Sulfadiazine on Burned Wound Healing in Rats. F Ü Sağ Bil Vet Derg 2009, 23, 135–139.
- Shahabi S, Hashemi S, Shahrokhi S, et al.: Hyperthermia can accelerate the healing process of 2nd degree burn wounds. J Kerman Univ Med Sci 2005, 3, 110–118.
- Eming SA, Krieg T, Davidson JM: Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol 2007, 127, 514–525.
- Werner S, Grose R: Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003, 83, 835–870.
- Roy H, Bhardwaj S, Yla-Herttuala S: Biology of vascular endothelial growth factors. FeBS lett 2006, 580, 2879–2887.
- Neal MS: Angiogenesis: is it the key to controlling the healing process? J Wound Care 2001, 10, 281–287.
- Hu YL, Guo SZ, Yan PS: effect of local application of basic fibroblast growth factor and sucralfate on skin tissue structure after expansion. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2002, 16, 340–344.
- Burch RM, McMillan BA: Sucralfate induces proliferation of dermal fibroblasts and keratinocytes in culture and granulation tissue formation in full-thickness skin wounds. Agents Actions 1991, 34, 229–231.
- Candelli M, Carloni E, Armuzzi A, Cammarota G, Ojetti V, Pignataro G, Santoliquido A, Pola R, Pola E, Gasbarrini G, Gasbarrini A: Role of sucralfate in gastrointestinal diseases. Panminerva Med 2000, 42, 55–59.
- Hollander D, Tarnawski A, Krause WJ, Gergely H: Protective effect of sucralfate against alcohol-induced gastric mucosal injury in the rat. Macroscopic, histologic, ultrastructural, and functional time sequence analysis. Gastroenterology 1985, 88, 366–374.
- Gupta PJ, Heda PS, Shrirao SA, Kalaskar SS: Topical sucralfate treatment of anal fistulotomy wounds: a randomized placebo-controlled trial. Dis Colon Rectum 2011, 54, 699–704.
- Konturek SJ, Konturek JE, Brzozowski T, et al.: effect of sucralfate on growth factor availability. In: Sucralfate: From Basic Science to the Bedside. Hollander D and Tytgat GNJ (eds). Plenum Medical Book Co., New York 1993, 175–189.
- Folkmann J, Szabo S, Stovroff M: Duodenal ulcer. Discovery of a new mechanism and development of angiogenic therapy that accelerates healing. Ann Surg 1991, 214, 414–426.
- Szabo S, Vattay P, Scarbrough E, Folkman J: Role of vascular factors, including angiogenesis, in the mechanisms of action of sucralfate. Am J Med 1991, 91, 158–160.
- McCarthy DM: Sucralfate. N engl J Med 1991, 325, 1017–1025.
- Da Costa RM, Ribeiro Jesus FM, Aniceto C, Mendes M: Randomized, double-blind, placebo-controlled, doseranging study of granulocyte-macrophage colony stimulating factor in patients with chronic venous leg ulcers. Wound Rep Reg 1999, 7, 17–25.
- Sweetman SC (ed): Sucralfate. In: Martindale: The Complete Drug Reference. 33rd edition, The Pharmaceutical Press, london 2002, 1250–1251.
- Wang X, Kimble RM: A review on porcine burn and scar models and their relevance to humans. Wound Pract Res 2010, 18, 41–49.
- Nexø E, Poulsen SS: Does epidermal growth factor play a role in the action of sucralfate? Scand J Gasteroenterol 1987, 125, 45–49.
- Mannari C, Santi S, Migliori M, Filippi C, Origlia N, Sansò M, Boldrini E, Giovannini L: Sucralfate modulates uPAR and eGFR expression in an experimental rat model of cervicitis. Int J Immunopathol Pharmacol 2008, 21, 651–658.
- Allain P, Mauras Y, Krari N, Duchier J, Cournot A, Larcheveque J: Plasma and urine aluminium concentrations in healthy subjects after administration of sucralfate. Br J Clin Pharm 1990, 29, 391–395.
- Fischer RS: Sucralfate a review of drug tolerance and safety, J Clin Gastroenterol 1981, Suppl. 2, 181–184.